Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Identification of ILK as a critical regulator of VEGFR3 signalling and lymphatic vascular growth.

Urner S, Planas-Paz L, Hilger LS, Henning C, Branopolski A, Kelly-Goss M, Stanczuk L, Pitter B, Montanez E, Peirce SM, Mäkinen T, Lammert E.

EMBO J. 2019 Jan 15;38(2). pii: e99322. doi: 10.15252/embj.201899322. Epub 2018 Dec 5.

2.

Mechanosensing by β1 integrin induces angiocrine signals for liver growth and survival.

Lorenz L, Axnick J, Buschmann T, Henning C, Urner S, Fang S, Nurmi H, Eichhorst N, Holtmeier R, Bódis K, Hwang JH, Müssig K, Eberhard D, Stypmann J, Kuss O, Roden M, Alitalo K, Häussinger D, Lammert E.

Nature. 2018 Oct;562(7725):128-132. doi: 10.1038/s41586-018-0522-3. Epub 2018 Sep 26.

PMID:
30258227
3.

Deletion of the RabGAP TBC1D1 Leads to Enhanced Insulin Secretion and Fatty Acid Oxidation in Islets From Male Mice.

Stermann T, Menzel F, Weidlich C, Jeruschke K, Weiss J, Altenhofen D, Benninghoff T, Pujol A, Bosch F, Rustenbeck I, Ouwens DM, Thoresen GH, de Wendt C, Lebek S, Schallschmidt T, Kragl M, Lammert E, Chadt A, Al-Hasani H.

Endocrinology. 2018 Apr 1;159(4):1748-1761. doi: 10.1210/en.2018-00087.

PMID:
29481597
4.

Mechanotransduction in Blood and Lymphatic Vascular Development and Disease.

Urner S, Kelly-Goss M, Peirce SM, Lammert E.

Adv Pharmacol. 2018;81:155-208. doi: 10.1016/bs.apha.2017.08.009. Epub 2017 Nov 10.

PMID:
29310798
5.

Exploring biological and social networks to better understand and treat diabetes mellitus: Comment on "Network science of biological systems at different scales: A review" by Gosak et al.

Belgardt BF, Jarasch A, Lammert E.

Phys Life Rev. 2018 Mar;24:146-148. doi: 10.1016/j.plrev.2017.12.004. Epub 2017 Dec 23. No abstract available.

PMID:
29289468
6.

Quantitative assessment of angiogenesis and pericyte coverage in human cell-derived vascular sprouts.

Eglinger J, Karsjens H, Lammert E.

Inflamm Regen. 2017 Jan 18;37:2. doi: 10.1186/s41232-016-0033-2. eCollection 2017.

7.

The Role of the Antioxidant Protein DJ-1 in Type 2 Diabetes Mellitus.

Eberhard D, Lammert E.

Adv Exp Med Biol. 2017;1037:173-186. doi: 10.1007/978-981-10-6583-5_11. Review.

PMID:
29147909
8.

NMDAR antagonists for the treatment of diabetes mellitus-Current status and future directions.

Welters A, Klüppel C, Mrugala J, Wörmeyer L, Meissner T, Mayatepek E, Heiss C, Eberhard D, Lammert E.

Diabetes Obes Metab. 2017 Sep;19 Suppl 1:95-106. doi: 10.1111/dom.13017. Review.

PMID:
28880473
9.

The biomechanical properties of an epithelial tissue determine the location of its vasculature.

Kragl M, Schubert R, Karsjens H, Otter S, Bartosinska B, Jeruschke K, Weiss J, Chen C, Alsteens D, Kuss O, Speier S, Eberhard D, Müller DJ, Lammert E.

Nat Commun. 2016 Dec 20;7:13560. doi: 10.1038/ncomms13560.

10.

Need for Better Diabetes Treatment: The Therapeutic Potential of NMDA Receptor Antagonists.

Welters A, Lammert E, Mayatepek E, Meissner T.

Klin Padiatr. 2017 Jan;229(1):14-20. doi: 10.1055/s-0042-117831. Epub 2016 Dec 14. Review.

PMID:
27975343
11.

DYRK1A: A Promising Drug Target for Islet Transplant-Based Diabetes Therapies.

Belgardt BF, Lammert E.

Diabetes. 2016 Jun;65(6):1496-8. doi: 10.2337/dbi16-0013. No abstract available.

12.

Exciting Times for Pancreatic Islets: Glutamate Signaling in Endocrine Cells.

Otter S, Lammert E.

Trends Endocrinol Metab. 2016 Mar;27(3):177-188. doi: 10.1016/j.tem.2015.12.004. Epub 2015 Dec 28. Review.

PMID:
26740469
13.

DJ-1 Protects Pancreatic Beta Cells from Cytokine- and Streptozotocin-Mediated Cell Death.

Jain D, Weber G, Eberhard D, Mehana AE, Eglinger J, Welters A, Bartosinska B, Jeruschke K, Weiss J, Päth G, Ariga H, Seufert J, Lammert E.

PLoS One. 2015 Sep 30;10(9):e0138535. doi: 10.1371/journal.pone.0138535. eCollection 2015.

14.

Effects of dextromethorphan as add-on to sitagliptin on blood glucose and serum insulin concentrations in individuals with type 2 diabetes mellitus: a randomized, placebo-controlled, double-blinded, multiple crossover, single-dose clinical trial.

Marquard J, Stirban A, Schliess F, Sievers F, Welters A, Otter S, Fischer A, Wnendt S, Meissner T, Heise T, Lammert E.

Diabetes Obes Metab. 2016 Jan;18(1):100-3. doi: 10.1111/dom.12576. Epub 2015 Oct 26.

15.

Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment.

Marquard J, Otter S, Welters A, Stirban A, Fischer A, Eglinger J, Herebian D, Kletke O, Klemen MS, Stožer A, Wnendt S, Piemonti L, Köhler M, Ferrer J, Thorens B, Schliess F, Rupnik MS, Heise T, Berggren PO, Klöcker N, Meissner T, Mayatepek E, Eberhard D, Kragl M, Lammert E.

Nat Med. 2015 Apr;21(4):363-72. doi: 10.1038/nm.3822. Epub 2015 Mar 16.

PMID:
25774850
16.

Identification, evolution and expression of an insulin-like peptide in the cephalochordate Branchiostoma lanceolatum.

Lecroisey C, Le Pétillon Y, Escriva H, Lammert E, Laudet V.

PLoS One. 2015 Mar 16;10(3):e0119461. doi: 10.1371/journal.pone.0119461. eCollection 2015.

17.

The dark side of islet vasculature.

In't Veld P, Lammert E.

Diabetologia. 2015 Jan;58(1):4-6. doi: 10.1007/s00125-014-3418-2. Epub 2014 Oct 18. No abstract available.

PMID:
25326240
18.

Blood and lymphatic vascular tube formation in mouse.

Neufeld S, Planas-Paz L, Lammert E.

Semin Cell Dev Biol. 2014 Jul;31:115-23. doi: 10.1016/j.semcdb.2014.02.013. Epub 2014 Mar 14. Review.

PMID:
24631829
19.

Mechanosensing in developing lymphatic vessels.

Planas-Paz L, Lammert E.

Adv Anat Embryol Cell Biol. 2014;214:23-40. doi: 10.1007/978-3-7091-1646-3_3. Review.

PMID:
24276884
20.

Mechanical forces in lymphatic vascular development and disease.

Planas-Paz L, Lammert E.

Cell Mol Life Sci. 2013 Nov;70(22):4341-54. doi: 10.1007/s00018-013-1358-5. Epub 2013 May 12. Review.

PMID:
23665871

Supplemental Content

Loading ...
Support Center